Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Privia Health Group

Privia Health Group Reaches 80-Plus Relative Strength Rating Benchmark

Privia Health Group sees its Relative Strength Rating reach the 80-plus level.

Investors Business Daily

Privia Health Group Earns IBD Stock Rating Upgrade

Privia Health Group Earns IBD Stock Rating Upgrade

Privia Health Group saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 94 the day before.

Investors Business Daily

Composite Rating For Privia Health Group Rises To 96

Composite Rating For Privia Health Group Rises To 96

Privia Health Group saw its IBD SmartSelect Composite Rating jump to 96 Thursday, up from 91 the day before.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stocks With Rising Relative Strength: Privia Health Group

Privia Health Group shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Earnings Outlook For Privia Health Group

Privia Health Group (NASDAQ:PRVA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Privia Health Group will report an earnings per share (EPS) of $-0.04.

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Expert Ratings for Privia Health Group

Analysts have provided the following ratings for Privia Health Group (NASDAQ:PRVA) within the last quarter:

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Where Privia Health Group Stands With Analysts

Where Privia Health Group Stands With Analysts

Within the last quarter, Privia Health Group (NASDAQ:PRVA) has observed the following analyst ratings:

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play